GTC Biotherapeutics (fka GTCB)

[OKY]

Yes the vote was yes:
FRAMINGHAM, MA – December 5, 2006 -- GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) reported today that its shareholders approved two proposals that will allow it to complete its proposed sales of securities to LFB Biotechnologies. The first proposal, approving an increase in the number of GTC’s authorized shares of common stock to 200 million, was passed by a vote of 40.6 million shares for the proposal and 3.5 million shares against, with 0.5 million shares abstaining. This exceeded the requirement that a majority of GTC’s outstanding voting stock vote in favor of the proposal. The second proposal, approving the issuance of 3,630,000 shares of common stock and a convertible note to LFB Biotechnologies in accordance with our agreement, was passed by a vote of 36.5 million shares for the proposal and 2.7 million shares against, with 0.4 million shares abstaining. This met the requirement for a majority of the votes cast to be in favor of the proposal.